Trastuzumab duration effects within patient prognostic subgroups in the PHARE trial von Kramar, A., Bachelot, T., Madrange, N., Pierga, J.-Y., Kerbrat, P., Espié, M., Fumoleau, P., Pauporté, I., Khayat, D., Romieu, G., Pivot, X.

Volltext

Abstract GS2-07: PHARE randomized trial final results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer von Pivot, X, Romieu, G, Debled, M, Pierga, J-Y, Kerbrat, P, Bachelot, T, Espie, M, Lortholary, A, Fumoleau, P, Serin, D, Jacquin, J-P, Jouannaud, C, Rios, M, Abadie-Lacourtoisie, S, Venat-Bouvet, L, Cany, L, Catala, S, Khayat, D, Gambotti, L, Pauporte, I, Faure Mercier, C, Paget-Bailly, S, Henriques, J, Grouin, J-M

Volltext

109TiPAcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types von Marabelle, A, Chevret, S, Janot, F, Escudier, B, Pouessel, D, Tournigand, C, Hoang-Xuan, K, Mortier, L, Rousseau, B J-C, Schlumberger, M J, Ray-Coquard, I L, Blay, J-Y, Niccoli, P, Jaccard, A, Couch, D, Hoog-Labouret, N, Pauporte, I, Massard, C

Volltext

Abstract P6-07-13: New insights on HER2 amplification from the constitutional and somatic standpoints: Results from the ICGC and SIGNAL/Phare studies von Vincent-Salomon, A, Ferrari, A, Pivot, X, Macgrogan, G, Arnould, L, Treilleux, I, Romieux, G, Sertier, A-S, Thomas, E, Tonon, L, Boyault, S, Kielbassa, J, Letexier, V, Pauporte, I, Birbaum, D, Saintigny, P, Cox, D, Viari, A

Volltext

Effects of HER2 immuno-histochemistry expression levels on survival in patients treated by trastuzumab at the adjuvant setting in the SIGNAL/PHARE prospective cohort von Curtit, E., Vincent-Salomon, A., Paget-Bailly, S., Romieu, G., Fumoleau, P., Bonnefoi, H., Jouannaud, C., Petit, T., Darut-Jouve, A., Trillet-Lenoir, V., Tarpin, C., Pierga, J.-Y., Rios, M., Jacquin, J.P., Bachelot, T., Cox, D., Deleuze, J.-F., Pauporte, I., Henriques, J., Pivot, X.

Volltext

First evaluation of the French cancer clinical research projects funding program (PHRC) von Pauporte, I., Brain, E. G., Hennequin, C., Auleley, G. R., Reiffers, J.

Volltext

Phare Trial Results Comparing 6 to 12 Months of Trastuzumab in Adjuvant Early Breast Cancer von Pivot, X., Romieu, G., Bonnefoi, H., Pierga, J.-Y., Kerbrat, P., Guastalla, J.-P., Lortholary, A., Espié, M., Fumoleau, P., Serin, D., Jacquin, J.-P., Jouannaud, C., Rios, M., Abadie-Lacourtoisie, S., Tubiana-Mathieu, N., Cany, L., Catala, S., Khayat, D., Pauporte, I., Kramar, A.

Volltext

A national survey on patients' enrollment rate in clinical trials: the French experience von Pauporté, I., Capra, L., Détry, S., Paoletti, X., Barbare, J.

Volltext

How to improve patients and investigators’ information on clinical trials: The example of French registry for clinical trials in oncology von Manach, E., Pauporté, I., Bachouche, N., Détry, S., Barbare, J.

Volltext

Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon study von Journot, Valérie, Pignon, Jean-Pierre, Gaultier, Claude, Daurat, Véronique, Bouxin-Métro, Annie, Giraudeau, Bruno, Preux, Pierre-Marie, Tréluyer, Jean-Marc, Chevret, Sylvie, Plättner, Valérie, Thalamas, Claire, Clisant, Stéphanie, Ravaud, Philippe, Chêne, Geneviève

Volltext

Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative von Bogaerts, J, Sydes, MR, Keat, N, McConnell, A, Benson, A, Ho, A, Roth, A, Fortpied, C, Eng, C, Peckitt, C, Coens, C, Pettaway, C, Arnold, D, Hall, E, Marshall, E, Sclafani, F, Hatcher, H, Earl, H, Ray-Coquard, I, Paul, J, Blay, JY, Whelan, J, Panageas, K, Wheatley, K, Harrington, K, Licitra, L, Billingham, L, Hensley, M, McCabe, M, Patel, PM, Carvajal, R, Wilson, R, Glynne-Jones, R, McWilliams, R, Leyvraz, S, Rao, S, Nicholson, S, Filiaci, V, Negrouk, A, Lacombe, D, Dupont, E, Pauporté, I, Welch, JJ, Law, K, Trimble, T, Seymour, M

Volltext bestellen

Chlorides, other Halides, and Pseudo-Halides as Additives for the Fabrication of Efficient and Stable Perovskite Solar von Cheng, Fei, Zhang, Jie, Pauporte, Thierry

Volltext

PEAI-Based Interfacial Layer for High-Efficiency and Stable Solar Cells Based on a MACl-Mediated Grown FA0.94MA0.06PbI3 Perovskite von Zhu, Tao, Zheng, Daming, Liu, Jiawen, Coolen, Laurent, Pauporté, Thierry

Volltext

Unveilling the Growth Mechanism of 2D, Quasi- 2D, Quasi-3D and 3D Halide Perovskite Thin Films von Pauporté, Thierry, Zheng, Daming

Volltext

Low‐Voltage UV‐Electroluminescence from ZnO‐Nanowire Array/p‐GaN Light‐Emitting Diodes von Lupan, Oleg, Pauporté, Thierry, Viana, Bruno

Volltext

Stabilizing Perovskite Precursor by Synergy of Functional Groups for NiOx‐Based Inverted Solar Cells with 23.5 % Efficiency von Li, Mengjia, Li, Haiyun, Zhuang, Qixin, He, Dongmei, Liu, Baibai, Chen, Cong, Zhang, Boxue, Pauporté, Thierry, Zang, Zhigang, Chen, Jiangzhao

Volltext

Impedance spectroscopy study of N719-sensitized ZnO-based solar cells von Pauporté, Th, Magne, C.

Volltext

Electrodeposition of Cu-doped ZnO nanowire arrays and heterojunction formation with p-GaN for color tunable light emitting diode applications von Lupan, O., Pauporté, T., Viana, B., Aschehoug, P.

Volltext

Molecular versus polymeric hole transporting materials for perovskite solar cell application von Ulfa, Maria, Zhu, Tao, Goubard, Fabrice, Pauporté, Thierry

Volltext

Lead‐ and Iodide‐Deficient (CH3NH3)PbI3 (d‐MAPI): The Bridge between 2D and 3D Hybrid Perovskites von Leblanc, Antonin, Mercier, Nicolas, Allain, Magali, Dittmer, Jens, Fernandez, Vincent, Pauporté, Thierry

Volltext